$8 Million Pharmacy NNN Acquisition
By Trevor Damyan, Commercial Mortgage Broker at Commercial Lending Solutions
An $8 million pharmacy net lease acquisition nationwide represents a core holding for institutional and individual investors seeking stable, long-term cash flow with minimal operational risk. At this loan size, borrowers typically acquire single-location or small multi-unit pharmacy properties anchored by investment-grade or strong regional tenant covenants, with lease terms ranging from 10 to 20 years and built-in rent escalations. Lenders at this price point emphasize tenant credit quality, remaining lease term, and property location over market dynamics, resulting in leverage between 60 to 75 percent LTV and all-in rates in the 6.00 to 6.50 percent range depending on loan structure. Non-recourse availability and favorable fixed-rate terms make this product attractive to 1031 exchange buyers and core-plus portfolios alike.
Get a Quote on Your $8M Deal →What a $8M Pharmacy NNN Acquisition Capital Stack Looks Like
National banks with established single-tenant net lease programs and life insurance companies dominate the $8 million pharmacy financing landscape, driven by their appetite for long-duration, investment-grade leases and ability to underwrite tenant credit independently of real estate cycles. Borrower profile, remaining lease term, and tenant tenant covenant strength typically determine whether a regional bank or life company leads execution, while CMBS conduits and credit unions compete on execution speed and recourse flexibility.
Pricing reflects active CLS CRE quote pipeline as of April 2026. Specific deal pricing depends on sponsor, property, and structure.
Who Closes a $8M Pharmacy NNN Acquisition Deal
Typical sponsors at the $8 million pharmacy NNN acquisition level include experienced net lease investors with $50 million to $500 million in portfolio value, multiple single-tenant acquisitions on record, and strong banking relationships. Common motivations include 1031 exchange portfolio repositioning, core-plus income allocation, and opportunistic acquisitions of high-credit tenants at favorable cap rates (4.50 to 6.00 percent range). Borrowers range from full-time CRE investment firms to high-net-worth individuals and family offices focused on passive, long-duration income.
A Real $8M Example
We closed an $8.0 million fixed-rate financing for a national pharmacy tenant operating from a secondary market property in the Upper Midwest. The sponsor, a 1031 exchange buyer, acquired the asset at a 5.50 percent cap rate with 18 years remaining on the lease and investment-grade tenant covenants. We placed the loan with a national bank offering 6.25 percent fixed at 70 percent LTV, fully non-recourse, closing in 38 days. The borrower benefited from stable monthly debt service, no recourse exposure, and flexibility to refinance in year seven as lease economics improved.
Anonymized. All deal references protect borrower and lender identity.
$8M Pharmacy NNN Acquisition FAQ
Get a Quote on Your $8M Deal
Tell us about your transaction. We will run it past lenders that actively fund this size and product type and send back terms within 48 hours.
Apply for Financing →